Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
Study Information
Alliance Study ID: CALGB-500105
NCT Study ID (ClinicalTrials.gov): NCT00049010
Disease or Cancer Type: Melanoma & Skin Cancers
Alliance Study Chair: F. Stephen Hodi, MD
Status: COMPLETED
Study Description
RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tissue and lymph node samples may help doctors identify patients with melanoma who are at risk for developing metastatic cancer.
PURPOSE: This clinical trial is studying tumor tissue and lymph node samples to see how well they work in predicting the development of metastatic cancer in patients with stage I or stage II melanoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information